Swiss Course on Medicinal Chemistry, Leysin, October 7-12, 2018
This five-day Medicinal Chemistry School that is organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society will focus on most modern aspects associated with small molecule drug discovery, highlighting the methodologies and technologies supporting hit generation, lead finding and lead optimization campaigns.
Visit the website: https://scmc18.chemistrycongresses.ch/en/
In the beautiful and scenic village of Leysin, close to Lake Geneva, more than 100 young scientists are expected to meet with app. 35 international renowned expert speakers and instructors.
As in previous years, the teaching content will be targeted at young scientists working in the area of medicinal chemistry, but also from flanking disciplines such as biochemistry, pharmacy, pharmacology, or biophysics from the pharmaceutical and biotech industry. Given the broad spectrum and the timeliness of scientific topics discussed, the course also provides a valuable opportunity for advanced medicinal chemists to get acquainted with most recent developments in e.g. the medicinal chemistry of novel target families, novel compound classes, and most modern optimization paradigms. In addition, a number of PhD students and postdocs will be able to attend to receive a broad overview on scientific disciplines involved in modern drug discovery.
The upcoming event will thematically be structured along key topics of strategic relevance for medicinal chemistry that will be presented by opinion leaders in the field. The teaching content will further be intensified by hands-on tutorials in which the theoretical learning’s can immediately be applied to real life problems of pre-clinical drug discovery.
Experts:
- Dr. Karin Briner, Vice President and Global Head of Discovery Chemistry at the Novartis Institute for BioMedical Research
- Dr. Nicholas A. Meanwell, Executive Director at Bristol-Myers Squibb
- Dr. Peter Grootenhuis, Senior Director at Vertex Pharmaceuticals
- Prof. Dr. Gerhard Klebe, Univeristy of Marburg
- Dr. Jonathan Mason, Drug Design and Computational Chemistry Expert at Heptares Therapeutics
- Dr. Andy Phillips, Chief Scientific Officer and President at C4 Therapeutics
David Spichiger, SCS
29.01.2018
Call for Nominations - EFMC 2018 Awards
To acknowledge outstanding achievements in the field of Medicinal Chemistry, EFMC is conferring every two years three Awards on the occasion of the International Symposium on Medicinal Chemistry. The 2018 Awards will be conferred on the occasion of the XXV EFMC "International Symposium on Medicinal Chemistry" (EFMC-ISMC) to be held in Ljubljana, Slovenia on September 2-6, 2018.
All 3 awards consist of a diploma, € 7.500 and an invitation for a lecture by the Award recipient at the upcoming EFMC-ISMC International Symposium on Medicinal Chemistry.
The EFMC-Awards include:
THE NAUTA AWARD FOR PHARMACOCHEMISTRY
For the advancement of Medicinal Chemistry and the development of international organizational structures in Medicinal Chemistry. The award will be given for outstanding achievements in the field of Medicinal Chemistry.
THE UCB-EHRLICH AWARD FOR EXCELLENCE IN MEDICINAL CHEMISTRY
To acknowledge and recognise outstanding research in the field of Medicinal Chemistry in its broadest sense by a young scientist. This Award has been established with the support of UCB Pharma.
THE PROUS INSTITUTE - OVERTON and MEYER AWARD FOR NEW TECHNOLOGIES IN DRUG DISCOVERY
To encourage innovation and investigation in technological development related to drug discovery, this Award established with the support of Prous Institute will be given for the discovery, evaluation or use of new technologies.
Nominations for these Awards consist of a nomination letter, a brief CV including a list of selected publications and two supporting letters. Self-nominations are also accepted. The nominations should be submitted to Dr Yves Auberson, President of the EFMC as of 2018, via the following link:
- Nomination for The Nauta Award for Pharmacochemistry
- Nomination for the UCB-Ehrlich Award for Excellence in Medicinal Chemistry
- Nomination The Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
Deadline for submission: January 31, 2018
More information on http://www.efmc.info
David Spichiger, SCS
08.11.2017
1st Alpine Winter Conference on Medicinal and Synthetic Chemistry
St. Anton, Austria - January 28 - February 1, 2018
The “Alpine Winter Conference on Medicinal and Synthetic Chemistry” exposes attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery. The main target audience for this highly interdisciplinary meeting will include medicinal and synthetic chemists, as well as related drug discovery disciplines from both industry and academia as well as graduate/undergraduate students and postdocs.
In the spirit of Keystone and Gordon conferences as well as the MBCF (Medicinal and Bioorganic Chemistry Foundation) conference in Steamboat Springs, the format of this meeting provides ample opportunity for attendees to informally interact. The aim is to strengthen existing networks and create new contacts.
For each of the below topics, a slot in the programme will be available for an oral communication selected out of the submitted abstracts. In addition, an open MedChem session on "Drug Discovery Tales" will have 3 open slots for oral communications. See instructions on "How to submit your abstract online".
The Conference topics will include:
- Addressing Preclinical Toxicity – Approaches and Lessons Learned (with panel discussion)
- Advances in Lead Generation
- Advances in Synthetic Methods
- Alternative Modalities
- Challenges and Opportunities in Fragment Based Drug Discovery
- Chemical Biology in Drug and Target Discovery
- Drug Discovery Tales
- Late Stage Functionalization
The official symposium language is English.
Scientific Organising Committee
- Dr Klemens HOEGENAUER (Novartis Institutes for BioMedical Research, Basel, Switzerland)
- Dr Karl Heinz KRAWINKLER (Novartis Institutes for BioMedical Research, Basel, Switzerland)
- Dr Antonia F. STEPAN (Pfizer, Cambridge, United States)
We are looking forward to welcoming you in beautiful St. Anton!
More information on the website of the conference
David Spichiger, SCS
01.09.2017
Int. conference “The Economics of Innovation: from Basic research to the Market”
The NCCR Chemical Biology is pleased to announce the 1st edition of the interdisciplinary and international conference “The Economics of Innovation: from Basic research to the Market” to be held from Sept. 04 to Sept. 06, 2017 in Geneva at the Brocher Foundation, interdisciplinary center.
The conference aims to determine the state of the art in the field of economic theory of innovation and stimulate further work to better understand the innovation process. Delegates will explore the rate-limiting or critical steps at each stage of the process and then carefully evaluate how different factors influence the outcome. We will bring together leading economists, managers, research scientists, scientists involved in policy and funding, experts from tech transfer and R&D in industry as well as venture capitalists. This unique event comprises extensive plenary sessions, ample time for discussion during round-table sessions and opportunities for interdisciplinary networking.
The conference will host 19 plenary lectures with international speakers from various prestigious institutions such as Prof. Venki Ramakrishnan, 2009 Nobel Prize in Chemistry, Group Leader of the Medical Research Council Laboratory of Molecular Biology in Cambridge and President of the Royal Society, UK or Prof. Maria Leptin, EMBO Director, Prof. Dietmar Harhoff, Director Max Planck Institute for Innovation and Competition and Prof. Marie Thursby, Georgia Institute of Technology.
Please visit the website of the conference to discover the outstanding list of speakers and the programme : https://theeconomicsofinnovation.org/ (flyer)
Registration deadline : June 15, 2017.
Participants will be admitted upon selection with a maximum of 60 participants total.
Registration includes (1) the conference fee, (2) 2 nights’ accommodation, (3) meals and coffee breaks and transportation during the event between the hotel, conference venue and restaurants.
Help us spread the word and share the news about this Conference with your colleagues and network!
Best regards,
Prof. Howard Riezman
Director of the NCCR Chemical Biology
Dr. Phaedra Simitsek
COO of the NCCR Chemical Biology
Université de Genève
Quai Ernest-Ansermet 30
1211 Genève 4
T: + 41 ( 0)22.37.96.407
www.nccr-chembio.ch
26th French-Japanese Symposium on Medicinal and Fine Chemistry
26th French-Japanese Symposium on Medicinal and Fine Chemistry
17th-20th September 2017, Strasbourg, France
http://fjs2017.unistra.fr
This conference brings together industrial and academic researchers from both countries with an interest in all cutting-edge aspects of organic chemistry, from synthetic methodology to medicinal chemistry. Besides the lectures given by invited speakers, a poster session will be organized to give every participant an opportunity to present his/her work. Scientific excellence and friendly exchanges are two important pillars of the FJS.
Contact
Cellule Congrès Unistra
19 rue du Maréchal Lefebvre
67100 Strasbourg
Phone : 0033 3 68 85 49 40
Rates
Academic: 400 €
Industry: 550 €
Student: 200 €
Gala Diner: 60 €
Important Dates
January conference registration opens
June 15th deadline for submission of abstracts
July 15th deadline for registraJon
Website
David Spichiger, SCS
10.02.2017
Page 268 of 296